Concept
Figure
Factors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports / Experiences and coping strategies among patients with mild COVID-19 who develop post COVID conditions at a primary care centre
""
Related Ideas
- FigureFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · A cross-sectional and population-based study from primary care on post-COVID-19 conditions in non-hospitalized patients
- Cohort StudyFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Introduction
- PCC TransitionsFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Changes over Time (PCC cohort 2021 until 2024)
- PCFS ChangesFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Changes over Time (PCC cohort 2021 until 2024)
- Survey RecruitmentFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Study population and recruitment
- Follow-up CohortFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Baseline characteristics second follow-up survey (March–September 2024)
- Cohort DemographicsFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Baseline characteristics first follow-up survey (July–August 2021)
- Model FindingsFactors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports · Factors associated with post-COVID condition (phase I, 2021)